Improving the detection and treatment of depression in Australians with multiple sclerosis: A qualitative analysis

Background: Depression is common in people with multiple sclerosis (MS), yet often goes undetected, untreated or undertreated. Objective: This qualitative research explored current practices, barriers and facilitators for detection and treatment of depression in Australians with MS. Methods: Participants were 26 people with MS recruited through social media. Participants completed the Centre for Epidemiological Studies Depression-Revised (CESD-R) scale and in-depth telephone or video interviews. Interviews were analysed using framework analysis. Results: Scores measured on the CESD-R proposed 73% of participants were experiencing severe depression symptoms. Participants reported that depression is not regularly and formally assessed through MS healthcare services and they are offered limited information about depression in MS. Barriers to mental health support included recognition of depression, resistance to treatment and limitations of collaborative support between general practitioners and MS healthcare services. Participants expressed a need for open conversations and information about depression during neurology consultations. Conclusion: Based on our findings, improved detection and treatment of depression in people with MS requires: 1) better provision of information about depression for people with MS through healthcare services and community organisations; 2) regular screening and assessment; 3) better healthcare services collaboration to improve management.

Automated summary

This study found significant issues in the detection and treatment of depression in people with multiple sclerosis, including a lack of formal assessment for depression and collaboration support between healthcare services. Participants generally believed that better provision of information about depression and improved identification and treatment of depression are needed.